ÔM

(Issy-les-Moulineaux, Hauts-de-Seine)

  • 1 Overview of the Icade Group

  • 2 Icade's Low-Carbon Strategy: aligning with a 1.5°C pathway

  • 3 Appendices

1. Overview of the Icade Group

1. OVERVIEW OF THE ICADE GROUP

ONE OF THE LEADING FRENCH LISTED REITS

QUAI 8.2, ÎLOT BC

Bordeaux, Gironde

OFFICE INVESTMENT: Icade, the leading real estate player in Greater Paris

  • • Portfolio as of 12/31/2020: €9.0bn (100%)

  • • Average net initial yield (1): 5.7%

  • • Development pipeline: €1.5bn (representing nearly 210,000 sq.m)

  • • Situated mainly in the Paris region, close to major Greater Paris stations

  • • 877,000-sq.m land bank

LE PARC POLYCLINIC (extension works)

HEALTHCARE INVESTMENT: Icade, the leading player in France

  • • French and international portfolio as of 12/31/2020: €5.7bn (100%) - 58.3% owned by Icade

  • • Average net initial yield (1): 5.3%

  • • Development pipeline: €0.45bn, deliveries up to 2024, 100% pre-let

  • • 175 healthcare facilities at the end of December:

    • o 92% in France, 8% in Europe (Italy and Germany)

      Caen, Calvados

    • o 86% short-term care facilities, 14% nursing home facilities

Icade shareholding structure

LE CONEX - Lille, Nord

  • (1) Group share, incl. duties

    PROPERTY DEVELOPMENT: a leading property developer in France, a key player in low-carbon construction

    • • Limited exposure (less than 10% of Group equity (1))

    • • A full-service developer (offices, homes, etc.)

      with extensive national coverage (21 local offices)

  • (2) Property Development equity attributable to the Group (before elimination of investments in subsidiaries / consolidated equity attributable to the Group)

  • (3) Including 0.72% of treasury shares and 0.26% for Icade's "FCPE" employee-shareholding fund

As of 12/31/2020

€14.7bn property portfolio

€11.8bn property portfolio excl. duties, Group share

Healthcare Investment

28%

Office Investment

72%

Free float (2)

42%

incl.

ICAMAP and other entities acting in concert 4.86%

S&P rating for Icade & Icade Santé

BBB+, stable outlook

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Icade SA published this content on 30 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 March 2021 09:22:07 UTC.